Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 15.01.2025
Cantourage Group SE
Not for release, publication or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction in which such release, publication or distribution would be unlawful. The important notes at the end of this announcement need to be observed.
Legalization of cannabis brings strong g [ … ]
Wed, 15.01.2025
Nordex SE
Highlights:
Order intake increased to 3.3 GW in Q4/2024
Stable pricing continued with ASP of EUR 0.90 million per MW in 2024
Full year 2024 order intake mainly driven by Germany, Türkiye, Canada, South Africa and Spain
Hamburg, 15 January 2025. The Nordex Group has significantly increased its order intake for 2024 by around 13 percent, reachin [ … ]
Wed, 15.01.2025
BRAIN Biotech AG
Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects
Group cash and cash equivalents improved to € 27.2 million
Successfully closed two milestone transactions with Royalty Pharma and Akribion Therapeutics
Management sees a strong start to the new financial year
Updated mid-term tar [ … ]
Wed, 15.01.2025
Swiss Re Ltd
Swiss Re Ltd
/ Key word(s): Personnel
Swiss Re proposes new members for election to the Board of Directors
15.01.2025 / 07:00 CET/CEST
Swiss Re proposes to elect Morten Hübbe and George Quinn as new Board of Directors members at the Annual General Meeting (AGM) on 11 April 2025
Philip Ryan and Sir Paul Tucker will n [ … ]
Wed, 15.01.2025
Formycon AG
Press Release // January 15, 2025
Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Otulfi®received MHRA approval for both subcutaneous and intravenous formulations, to treat serious inflammatory diseases
UK approval follows the series of successful approvals by the FDA, the European Co [ … ]
Wed, 15.01.2025
dynaCERT Inc.
Company Name:
dynaCERT Inc.
ISIN:
CA26780A1084
Reason for the research:
Management Interview
Recommendation:
Management Interview
Last rating change:
Analyst:
Matthias Greiffenberger, Marcel Goldmann
Bernd Krüper: First, I would like to emphasize based on my more than 30 years of professional experience in the automotive s [ … ]
Wed, 15.01.2025
Bossard Holding AG
Dear Sir or Madam,
Enclosed you find the ad hoc announcement pursuant to Art. 53 LR of Bossard Holding AG of January 15, 2025.
Press Release (PDF)
Further information is available on www.bossard.com – Investor Relations.
If you would like to unsubscribe from the mailing list, please click here: Unsubscribe
Yours sincerely,
Bossar [ … ]
Wed, 15.01.2025
Information Services Department, Hong Kong SAR Government
EQS Newswire / 15/01/2025 / 04:40 CET/CEST
HONG KONG SAR - Media OutReach Newswire - 14 January 2025 - Around 3,600 policymakers, business leaders, investors and scholars from around the world are attending the 18th Asian Financial Forum (January 13-14) in Hong Kong, the region's first major finance event in 2025. Themed "Powering the Next Gro [ … ]
Tue, 14.01.2025
LM Pay S.A.
Warsaw, January 14, 2025 – LM PAY SA, listed on the Primary Market of the Düsseldorf Stock Exchange (ISIN: PLLMPAY00016), a first choice lender for financing medical, dentistry and aesthetics treatments, announces that at today's meeting the Supervisory Board approved appointment of a new Board member.
CEO Jakub Czarzasty commented:
"I would like [ … ]
Tue, 14.01.2025
Vulcan Energy Resources Limited
Production of battery quality lithium hydroxide monohydrate First fully integrated production in Europe of battery quality lithium chemicals,
from resource to final product
Vulcan Energy Resources Limited (Vulcan, ASX: VUL, FSE: VUL, the Company) is pleased to announce that production of Lithium Hydroxide Monohydrate (LHM) has met product [ … ]